Abu Dhabi Islamic Bank (ADIB), a leading financial institution, has launched a new healthcare-focused equities basket note. The structured note provides 95% capital protection, while offering no cap on the potential return and matures in 12 months.

Saif Alkeem, Head of Wealth Management & Priority Banking at ADIB, said:

“Healthcare is one of the sectors that has seen strong investor interest during this pandemic induced era. The launch of this new Sharia’a-compliant healthcare equity basket note provides exposure to leading international healthcare companies primed to capitalise on such trends in a post-COVID-19 world. It is expected to offer strong returns with limited risk to their capital. 

“As a bank, we will continue to develop tailored wealth management solutions to customers which allow them to meet their financial goals through a diversified investment portfolio.”

Healthcare stocks have received considerable attention over the last year due to COVID-19, which has increased the need for effectual treatments and a race for a proven, safe vaccine. The Sharia’a-compliant product matures in one year and provides investors with access to leading international healthcare companies and is designed to capture the projected growth of companies involved in the research & development, manufacturing, and selling of treatments, medicines, and vaccines. Stocks include Merck & Co, Gilead Sciences, Johnson & Johnson, Sanofi and Novartis, which have a diversified portfolio of pharmaceutical products that attract consistent demand around the world.

The note is open for subscription until 4 February 2021 with a minimum investment commitment of $50,000. Customers will have the option to redeem their investment after a three-month lock-in period.

As one of the UAE’s leading banks, ADIB has a strong track record developing and delivering best-in-class solutions tailored to meet the financial needs of customers, and across financial planning and asset allocation.

Send us your press releases to pressrelease.zawya@refinitiv.com

© Press Release 2021

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.